Share Article
SANTA MONICA, Calif., Sept. 3, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc., (Nasdaq:KITE) today announced that the management team will participate in two upcoming investor conferences this month:
- 10th Annual Citi Biotech Conference
Date: Thursday, September 10, 2015Time: 11:00am Eastern TimeLocation: New York, NY
- Morgan Stanley Global Healthcare Conference
Date: Thursday, September 17, 2015Time: 1:30pm Eastern TimeLocation: New York, NY
The Company's corporate overview to be presented at the Morgan Stanley Global Healthcare Conference will be available through the Calendar of Events section of the Company's website at ir.kitepharma.com.
About Kite Pharma
Kite Pharma, Inc., is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA. For more information on Kite Pharma, please visit www.kitepharma.com.
CONTACT: Kite Pharma
Cynthia M. Butitta
Chief Financial Officer and Chief Operating Officer
310-824-9999
For Media: Justin Jackson
For Investor Inquiries: Lisa Burns
Burns McClellan
212-213-0006
jjackson@burnsmc.com
lburns@burnsmc.com
Other News
Some of the content on this page is not intended for users outside the U.S.